New Research Young Investigator Poster Session 5
Scientific and Clinical Report
SCR19. Historical and Research Issues
63. The Participation of German Physicians in the So-Called "Euthanasia Program" During the Third Reich: Motivations, Verdicts,
and Sentences Robert McKelvey, M.D.
64. Development of a Comorbidity Index for Mental Health Dianne Groll, Ph.D.
65. Dreaming With Jung: Carl Jung's Red Book and Critical Implications for Psychiatric Practice 90 Years Later Scott Simpson, M.D., M.P.H.
66. Risks of Readmission in Patients Diagnosed With Bipolar, Major Depressive, or Schizoaffective Disorders: A Longitudinal
Study Stephen Woolley, D.Sc., M.P.H.
W51. Charting the Next Frontier in Psychiatry: The Applications, Barriers, and Impact of Telepsychiatry on Mental Health CareChairs: Sonya Lazarevic, M.D., M.S.W., Steven E. Hyler, M.D.
W52. Approaching Attention-Deficit Disorder in University Populations: Dosing, Diagnosing (and Detecting Those Just Looking
for a Buzz)Chairs: Gordon D. Strauss, M.D., Beverly Fauman, M.D.
W53. Psychiatry at a Crossroads: Our Changing Role in the House of MedicineAPA Council on Psychosomatic Medicine and Geriatric Psychiatry; Chair: Christopher W. Tjoa, M.D., B.S.
W54. Motivational Therapy for Individuals With Concurrent DisordersChair: Shimi Kang, M.D.
W55. Making the Most of Your Chief Year: Chief Residents' Forum IChair: Jonathan Amiel, M.D.(Open to residents only)
W56. Patient Suicide During Psychiatry Residency: A Workshop DiscussionChairs: Meredith A. Kelly, M.D., Emily Gastelum, M.D.
W57. Collateral Damage: Teaching Residents About the Impact of Patient SuicideChairs: Joan M. Anzia, M.D., Glen O. Gabbard, M.D.
W58. Dynamic Therapy With Self-Destructive Borderlines: An Alliance-Based Intervention for SuicideChair: Eric M. Plakun, M.D.
CC2. Linking Medicine and Psychiatry: Clinical Cases in Psychosomatic MedicineChair: Michelle B. Riba, M.D., M.S.
Treatment-Resistant DisordersChair: Charles B. Nemeroff, M.D.,
F3.DSM-5: Research and DevelopmentChairs: David J. Kupfer, M.D., Darrel A. Regier, M.D.
L11. Wrongful Convictions: Challenges for Psychiatry and Forensic ScienceChair: Barry Scheck, J.D.
L12. Distinguished Psychiatrist LectureNational Institute of Mental Health; Chair: David Lewis, M.D.
L13. Judd Marmor Award LectureChair: Lawrence Siever, M.D.
Small Interactive Sessions
SI04. Opportunities in the Addiction Field: What You Should Know About Treatment, Training, and ResearchChair: Marc Galanter, M.D.(Open to residents only)
SI05. Patients With Personality DisordersChair: John M. Oldham, M.D., M.S.(Open to residents only)
W59. The War: Understanding and Confronting Scientology's Efforts to Destroy PsychiatryChair: Stephen R. Wiseman, M.D.
W60. High-Yield Cognitive-Behavioral Therapy for Brief SessionsChair: Jesse H. Wright, M.D., Ph.D.
AR1. Advances in ResearchChair: Herbert Pardes, M.D.
Anxiety Disorder in Children and Adolescents: State-of-the-Art Assessment and Treatment John Walkup, M.D.
Posttraumatic Stress Disorder, Major Depression, and the Risk for Suicidal Behavior Maria Oquendo, M.D.
Successful Cognitive Aging and Wisdom Dilip V. Jeste, M.D.
Depression and Diabetes: Unhealthy Bedfellows Wayne Katon, M.D.
MW5. Psychotherapeutic Augmentation of Medication Checks Using Functional Analytic Psychotherapy (FAP)Chairs: Grant Miller, M.D., Barbara Kohlenberg, Ph.D.
PS3. Psychiatry and Primary Care Collaboration Under Health Care Reform: Sustainable Models That Improve Access and QualityChair: Henry Chung, M.D.
Collaborative Care for College Students: The National College Depression Partnership (NCDP) Henry Chung, M.D.
Health Plan Implementation of Primary CareâBased Behavioral Health Services Hyong Un, M.D.
Improving Mental Health Care for Medical Outpatients: A Co-Location Model Using Psychiatrists in Urban Primary Care Settings
Bruce Schwartz, M.D.
Improving Medical Care of Patients Receiving Behavioral Health Care Joseph Parks, M.D.
Achieving Comprehensive, Sustainable Models of Care in the Patient-Centered Medical Home Under Health Care Reform Frank Degruy, M.D.
S34. Updates on Psychological Impacts of the Wars in Afghanistan and Iraq: Best Modalities of Screening and Treatment
Managing the Effects of Combat Trauma: The Evolving Practice at Walter Reed Army Medical Center John Bradley, M.D.
Managing the Effects of Combat Trauma: The Evolving Practice at Walter Reed Army Medical Center Scott Moran, M.D.
The Pacific Psychological Health Task Force: Enhancing Treatment Through Establishment of Partnerships in the Pacific Region
Carroll Diebold, M.D.
Pharmacotherapy for PTSD in Combat Veterans: Challenges and Opportunities David Benedek, M.D.
Building DoD/VA/State and Community Partnership in Service to OEF/OIF Veterans and Their Families: Military Culture and Community
Competence Harold Kudler, M.D.
S35. Teaching What Every Psychiatrist Needs to Know About Neuroscience
Teaching Neuroscience to Psychiatry Residents: What to Teach and How to Teach It Mayada Akil, M.D.
Integrating Neuroscience in the Training of Psychiatrists: The Yale Experience David Ross, M.D., Ph.D.
Organizing a Neuroscience Course Around the Research Domain Criteria Project (RDoC) Amit Etkin, M.D., Ph.D.
S36. The Shrinking Psychotherapeutic Pipeline: Why Has the Spigot Been Turned Off?
Increasing the Validity of Animal Models of Depression by Genetic-Environment Interactions Irwin Lucki, Ph.D.
New Drugs to No Drugs: Antidepressants and Drug Discovery/Development David Michelson, M.D.
Cross-Species Tests for Cognition Enhancement in Schizophrenia Mark Geyer, Ph.D.
Alzheimer's Disease Clinical Trial Failures: Ineffective Drugs or Flawed Clinical Trials? Nigel Greig, Ph.D.
S37. Is Whole Person Psychiatry Possible?
Whole Person Care in Psychiatry and in Palliative Medicine John Peteet, M.D.
Clinical Implications of Research on Healthy Personality Functioning C. Robert Cloninger, M.D.
Patient Preferences and Values: The Connecting Thread Between Evidence-Based Medicine and Cultural Competence Francis Lu, M.D.
Spirituality and Health: Guidelines for Clinical Care and Curriculum Development Christina Puchalski, M.D.
Comprehensive Treatment of Complex Patients: The Psychiatrist's Role Nadine Nyhus, M.D., M.A.
S38. Integrating Couples and Family Treatment Into Patient Care
How to Do a Biopsychosocial Formulation and Use Diagnostic Reasoning and Clinical Decision Making That Involve the Family
Alison Heru, M.D.
Different Models of Family Intervention and Their Application to Psychiatric Disorders, Symptoms, and Situations Ira Glick, M.D.
S39. Harm Reduction and Prevention of Stalking
Stalking of Health Care Professionals: Reducing the Risk Gail E. Robinson, M.D.
Treatment of Stalkers Werner Tschan, M.D.
Stalking Behavior Among Juveniles: Opportunities for Early Intervention Rosemary Purcell, Ph.D.
Assessment and Management of Stalking and Threatening Activity in Campus Settings Mario Scalora, Ph.D.
S40. Evidence-Based Outcomes in Psychiatry: Updates on Measurement Using Patient-Reported Outcomes (PRO)APA Task Force on DSM-5
Patient-Reported Outcome Measures in DSM-5 William Narrow, M.D., M.P.H.
Patient Reported Outcomes Measurement Information System (PROMIS): Overview and Applications for Mental Health Research William Riley, Ph.D.
Patient-Reported Outcome Measure in Clinical TrialsâAn FDA Perspective June Cai, M.D.
International Pilot Study on Patient-Reported Outcomes in Schizophrenia Massimo Moscarelli, M.D.
S41. Longitudinal Course and Outcome in Borderline Personality Disorder
Parental Viewpoints on Trajectories to the Development of Borderline Personality Disorder in Males Marianne Goodman, M.D.
Rates of Recurrence of the Symptoms of BPD after Sustained Symptomatic Remission Mary Zanarini, Ed.D.
Prospective Predictors of Suicide Attempts in Borderline Personality Disorder at Six-Year Follow-Up Paul Soloff, M.D.
Prospective Risk Factors for Suicide Attempts in a Treated Sample of Patients With Borderline Personality Disorder (BPD) Paul Links, M.D.
S42. Madness and the City: Facing De- and Re-Institutionalization in Western European Metropolises
Characteristics and Impact of De- and Re-Institutionalization in Western Europe JosÃ©phine Caubel, M.D.
Cities as Creators of Madness Wilco Tuinebreijer, M.D.
Integrative Care: The Way From Hospital to Outpatient Settings in Germany JÃ¼rgen Gallinat, Ph.D., M.D.
Birmingham: An Integrated Model of Hospital and Community Mental Health Service Provision Mervyn Morris, M.A., Ed.D.
Assertive Community Treatment in Amsterdam: The Dutch Answer to Deinstitutionalization Jeroen Zoeteman, M.D.
S43. Placebo Effects in Psychiatry
The Psychology and Psychodynamics of the Placebo Response Javier Garcia, M.D.
Placebo Effect in Clinical Trials Intikhab Ahmad, M.D.
Ethical Dilemmas in the Use of Placebo Joel Idowu, M.D.
The Neurobiology of Placebo Effects William Head, M.D.
The Placebo Effects in Clinical Practice Sheldon Blackman, Ph.D.
Scientific and Clinical Reports
SCR 20. Miscellaneous Topics/Diagnostic Issues
67. Visualizing Mental Diseases: Distinct Plasma Levels of Cytokines and Chamokines in Schizophrenia and Major Depressive
Disorder Sekiyama Atsuo, M.D., Ph.D.
68. Conversion Disorder Presenting as Hemiplegia in a Patient With Familial Hemiplegic Migraine George Paris, M.D.
69. Diagnostic Stability in Major Depressive Disorder With Versus Without Psychotic Features John Goethe, M.D.
W61. Guardianship and Advance Directives in PsychiatryChair: RenÃ©e M. Sorrentino, M.D.
W62. Behavioral Addictions: New Category in DSM-5Chairs: Ken Rosenberg, M.D., Charles O'Brien, M.D., Ph.D.
W63. Gender-Specific Neurobiological, Behavioral, and Social Influence on Human Development: Implications for Heterosexual
Relationships and Couples TherapyChair: Scott D. Haltzman, M.D.
W64. Examining the Social Determinants of Mental Health Among Various Racial/Ethnic PopulationsChairs: Ruth S. Shim, M.D., M.P.H., Monica Taylor-Desir, M.D., M.P.H.
W65. Making the Most of Your Chief Year: Chief Residents' Forum IIChair: Jonathan Amiel, M.D.(Open to residents only)
W66. Professional Transitions: The PGY-4 Journey Through Terminations and Graduation to "Real Life"Chair: Joan M. Anzia, M.D.
W67. NIMH Psychopharmacology Trials: How the Results Inform PracticeChair: Adelaide S. Robb, M.D.
AM2. Update on Epilepsy: The Diagnosis and Management of Patients With "Spells"Chair: Alan G. Stein, M.D.
Substance AbuseChair: Marc Galanter, M.D.
New Research Poster Session 6
L14. Disease Biomarkers for Schizophrenia: From Laboratory to Patient BedsideChair: Sabine Bahn, M.D.
L15. The Alienist in the 21st CenturyChair: Dinesh Bhugra, M.B.B.S., Ph.D.
L16. 30 Years' Experiences in Providing Mental Health Care to Asian Refugees and ImmigrantsChair: Paul Leung, M.D.
L17. Transforming Clinical Outcomes in AddictionChair: Nora D. Volkow, M.D.
Small Interactive Sessions
SI06. Child Psychopharmacology: Current ControversiesChair: Barbara J. Coffey, M.D., M.S.
SI07. Top 10 Geriatric Psychiatry Issues for the General PsychiatristChair: Josepha A. Cheong, M.D.
W68. Does the Brain Ever Recover From Drug Addiction?National Institute on Drug Abuse; Chair: Steven Grant, Ph.D.
W69. Computer-Assisted Cognitive Behavioral Therapy (CCBT): Practical Implications for Everyday PracticeChairs: Jesse H. Wright, M.D., Amanda B. Mackey, M.D., Sarah B. Johnson, M.D., M.Sc.
W70. Challenges in Treating andEvaluating PhysiciansChair: Glen O. Gabbard, M.D.
CC3. Evaluating and Treating the Psychological Effects of WarChairs: Elspeth C. Ritchie, M.D., Marvin Oleshansky, M.D.
F5. Health Reform: Transforming Addiction Services in the United StatesNational Institute on Drug Abuse; Chairs: Wilson M. Compton, M.D., Nora D. Volkow, M.D.
L19. Alexandra Symonds Award Lecture (moved to IPS meeting)
L19. Stress, Cortisol, and Psychosis in DepressionChair: Alan F. Schatzberg, M.D.
MW6. "Out in the Silence": A Film About Being Gay or Lesbian in Small-Town AmericaAmerican Academy of Child and Adolescent Psychiatry; Chair: Richard R. Pleak, M.D.
Scientific and Clinical Reports
SCR 21. Psychopharmacology 2
70. Bruxism and Antidepressants Harvinder Singh, M.D.
71. Rapid Response of Disabling Tardive Dyskinesia to a Short Course of Amantadine Gaurav Jain, M.D.
72. Current Prescribing Practices: Antipsychotic Polypharmacy in Patients With Schizophrenia and Schizoaffective Disorder
John Bonetti, D.O.
73. Prescription Rates of Selective Serotonin Reuptake Inhibitors (SSRIs) After Introduction of Generic Equivalents: A Population-Based
Study James Bolton, M.D.
SCR 22. Schizophrenia and Other Psychotic Disorders 2
74. Parsing the Heterogeneity of Schizophrenia: The Utility of Four Early-Course Features in Subtyping First-Episode Nonaffective
Psychosis Michael Compton, M.D., M.P.H.
75. Mood Symptoms in Patients Presenting With Primary Psychosis After Age 40: A Prospective Cohort Study Rebecca Anglin, M.D.
76. A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole
to Reduce Metabolic Risk Thomas Stroup, M.D., M.P.H.
77. Meta-analysis of Phase 3 Trials of Iloperidone in the Short-Term Treatment of Schizophrenia: Efficacy Outcomes Based on
Pretreatment Status Stephen Stahl, M.D., Ph.D.
Small Interactive Sessions
SI08. Successful Cognitive and Emotional Aging: How Can We Get There?Chair: Dilip V. Jeste, M.D.
SI09. Management of Anxiety and Depression in the Medically IllChair: Catherine C. Crone, M.D.
W71. Diagnostic Assessment in DSM-5: Approaches and ExamplesAmerican Psychiatric Institute for Research and Education; Chairs: David J. Kupfer, M.D., Darrel A. Regier, M.D.
W72. Mental Health Issues and the Law of DeportationAPA Council on Psychiatry and Law; Chair: Patricia R. Recupero, J.D., M.D.
W73. Primary Care Behavioral Health Integration: Roles of the Key Team MembersChair: Lori Raney, M.D.
W74. The Older Adult Driver With Dementia: Safety Concerns and Physician InterventionsAPA Council on Adult Psychiatry; Chair: Helen H. Kyomen, M.D., M.S.
W75. Models for Ma ximizing Clinical Revenues and Supporting the Academic Mission: A Joint Presentation of the AACDP and AAPChairs: Paul Summergrad, M.D., Radmila Bogdanich, M.A.
W76. Going International: Improving International Medical Graduates' Training Experiences During Psychiatry ResidencyChair: Sanjeev Sockalingam, M.D.
W77. What Have You Done for Me Lately: Identifying Early Career Psychiatrists' Needs and Resources Within the APA Membership
CommitteeChair: Nioaka N. Campbell, M.D.
A3. Advances in PsychotherapyChair: Glen O. Gabbard, M.D.
1. Psychotherapies for Hyperarousal and Dissociative Subtypes of PTSD: Similarities and Differences David Spiegel, M.D.
3. Psychotherapy With Suicidal Patients Barbara H. Stanley, Ph.D.
4. Psychotherapy Plus: Medication for Addictive Disorders Charles O'Brien, M.D., Ph.D.
5. Psychotherapy Induces Proliferation of Brain Serotonin 5-HT1A Receptors but Does Not Influence Dopamine D2/3 Receptors
in Patients With Major Depressive Disorder Hasse Karlsson, M.D., Ph.D.
PS4. Translating Neuroscience for Advancing Treatment and Prevention of Posttraumatic Stress DisorderChair: Charles Marmar, M.D.
Reconsolidation Blockade as a Novel Strategy for Treating PTSD Charles Marmar, M.D.
Targeting Peptides for Novel Pharmacological Treatments of PTSD Thomas Neylan, M.D.
Neuroscience Informed Strategies for Early Intervention for PTSD Arieh Y. Shalev, M.D.
Interrupting the Intergenerational Transmission of Trauma by Treating Maternal PTSD and Optimizing Maternal Care Claude M. Chemtob, Ph.D.
S44. Comprehensive HIV Psychiatry Update
HIV/AIDS Medical Update The Very Right Rev. Drew A. Kovach, M.D., M.Div.
Neuropsychiatric Overview Marshall Forstein, M.D.
Neurocognitive Decline Karl Goodkin, M.D., Ph.D.
Psychopharmacology Stephen Ferrando, M.D.
S45. Research Update: New Developments in the Treatment of Mood DisordersNational Institute of Mental Health
New Insight Into the Neurobiology of Depression and the Development of Rapid-Acting Antidepressants and Biomarkers of Response
Carlos Zarate, M.D.
Combining Medications to Enhance Depression Outcomes (CO-MED) Madhukar Trivedi, M.D.
TMS, Magnetic Seizure Therapy in Animals Holly Lisanby, M.D.
The NIMH Bipolar Trials Network Lithium Treatment Moderate Dose Use Study (LiTMUS): A Randomized, Comparative Effectiveness
Trial of Adjunctive Lithium Joseph Calabrese, M.D.
S46. Recovery: Practical and Policy Lessons From Around the World
The Experience of Soul/Atman/Center/Hara/Seika Tanden/Spirit as an Essential Element of Being Necessary for Flourishing to
Progress to Recovery Carl C. Bell, M.D.
The Impact of Health Reform on the Recovery Movement in America Steven Sharfstein, M.D., M.P.A.
Recovery: Practical and Policy Lessons From Around the World Jair Mari, M.D.
Recovery, Psychiatry, and Federal Mental Health Policy in the U.S. Kenneth Thompson, M.D.
S47. Treatment-Resistant Depression: A Roadmap for Effective Care
Treatment-Resistant Depression: Overview of the University of Michigan Depression Center Roadmap John F. Greden, M.D.
Psychopharmacological Roadmap for Treatment-Resistant Depression Srijan Sen, M.D.
Treatment-Resistant Depression Among Adolescents Neera Ghaziuddin, M.D.
Treatment-Resistant Depression: A Roadmap for Effective Care Michelle B. Riba, M.D.
Device-Related Neuromodulation in Treatment-Resistant Depression Daniel Maixner, M.D.
S48. Psychiatric Malpractice: Maintaining Solid Footing on Shaky Ground
Important Clinical and Legal Concepts Pertaining to Psychiatric Malpractice Craig Beach, M.D., M.Sc.
Cases to Illustrate Practical Strategies to Minimize Malpractice Risk and Navigate the Legal System in the Event of a Lawsuit
Praveen Kambam, M.D.
What Really Occurs During a Malpractice Action Louis DelSignore, J.D.
Potential Emotional, Ethical, and Practical Implications of Being Sued Carolyn Wolf, J.D., M.S.
S49. Challenges and Conflicts in Professional Leadership at Psychiatric Institutions
Challenges and Conflicts in Professional Leadership at Psychiatric Institutions Robert Michels, M.D.
The Evolving Clinical-Administrative Function Richard Munich, M.D.
S50. Neural Correlates of Rapid Eye Movement (REM) and Dreaming: Implications for Dream Theory
Human Genotypic and Phenotypic Adaptations to Their Environments Jimmie Harris, D.O.
fMRI Evidence for Multisensory Recruitment Associated With Rapid Eye Movements During Sleep Charles Chong-Hwa Hong, M.D., Ph.D.
Imaging Correlates of Lucid Dreaming Renate Wehrle, Ph.D.
Quantitative EEG Correlates of Lucid Dreaming Ursula Voss, Ph.D.
S51. Bipolar Disorder: Controversies in Epidemiology and Treatment in Children and Adults in the U.S. and France: Vive la
More Childhood-Onset Bipolar Illness in the U.S. Than in Europe Robert Post, M.D.
Bipolar Disorder: Under- or Overdiagnosed Jean Michel Azorin, M.D.
Bipolar Disorder in Youth: Controversies in the U.S. and Abroad Robert Hendren, D.O.
Treatment Recommendations: The French Experience Philippe Courtet, M.D., Ph.D.
Prevalence and Characteristics of Bipolar Disorders in Patients With a Major Depressive Episode Charles Bowden, M.D.
The Challenge of Bipolar Depression Diagnosis and Treatment FranÃ§ois Petitjean, M.D.
S52. Psychiatric and Behavioral Genetics: Ethical and Legal Challenges
Psychiatric and Behavioral Genetics and the Eugenic Legacy Paul S. Appelbaum, M.D.
Prenatal Genetic Screening for Psychiatric Disorders and Behavioral Traits Mildred Cho, Ph.D.
Newborn Genetic Screening: Legal and Ethical Concerns Steven Hoge, M.D., M.B.A.
Is Epigenetics a New Paradigm for Understanding Behavior? Nancy Press, Ph.D.
Ethical Issues in Psychopharmacogenetic Testing Jinger Hoop, M.D.
S53. What's the Difference That Makes the Difference? Commonalities and Differences Across Efficacious Treatments for BPD
Mentalization Based Treatment (MBT) and its Relationship to Other Psychotherapies for Borderline Personality Disorder Anthony Bateman, M.D.
Transference-Focused Psychotherapy: The Relationship in the Here-and-Now as the Key Frank Yeomans, M.D., Ph.D.
Dialectical Behavior Therapy Linda Dimeff, Ph.D.
TARA DBT-MBT Family Training Valerie Porr, M.A.
S54. Predictors, Moderators, and Mediators in Major Depressive Disorder
Predictors, Moderators, and Mediators of Symptom Improvement in Major Depressive Disorder: Focus on Clinical Factors George Papakostas, M.D.
Pharmacogenomics of Major Depression Julio Licinio, M.D.
Phosphorus-31 MRS Studies of High Energy Phosphates in MDD: Implications for Treatment Response and Novel Therapies Perry Renshaw, M.D., Ph.D.
Neurophysiologic Biomarkers for Predicting Treatment Outcome in MDD Andrew Leuchter, M.D.
S55. The Use of QEEG for Psychiatric Treatment Biomarkers
ATR-A QEEG-Based Biomarker of Treatment Response in Major Depression Dan Iosifescu, M.D., M.Sc.
Referenced-EEG (rEEG) Daniel Hoffman, M.D.
iSPOT Evian Gordon, Ph.D.
S56. Advances on Suicide Prevention: Preventing the Predictable
Personality and Life Events as Predictive Factors of Suicidal Behavior Hilario Blasco-Fontecilla, M.D., Ph.D.
Predictive Models in Suicidal Behavior Jorge Lopez-Castroman, M.D., Ph.D.
Novel Classification Tools for Suicide Prediction Fernando Perez-Cruz, B.Sc.
Data Mining, Suicide, and More: Our Experience M. Mercedes Perez-Rodriguez, M.D., Ph.D.
Implementation of All These Novel Tools in the Prevention of Suicide Jose de Leon, M.D.
S57. Collaborative Strategies Between Psychiatrists and Judges to Improve Outcomes for Defendants With Mental Illnesses
Overview of Topic Fred C. Osher, M.D.
The Judge's Role Steven Leifman, J.D.
Collaborative Strategies Between Psychiatrists and Judges to Improve Outcomes for Defendants With Mental Illnesses Annelle Primm, M.D., M.P.H.
How the Issue Impacts Hawaiians Marcia Waldorf, J.D.